PureTech Health (PRTC) Amortization (2023 - 2025)

PureTech Health (PRTC) has 3 years of Amortization data on file, last reported at -$44.8 million in Q2 2025.

• Amortization for Q2 2025 came in at -$44.8 million, up 8.39% year-over-year; the trailing twelve-month figure through Jun 2025 was -$168.1 million (changed N/A YoY), and the FY2024 annual result was -$48.9 million, down 188.69% from the prior year.
• Amortization improved to -$44.8 million in Q2 2025 per PRTC's latest filing, from -$48.9 million in the prior quarter.
• Over five years, Amortization peaked at -$25.6 million in Q4 2023 and troughed at -$48.9 million in Q2 2024.
• A 3-year average of -$42.0 million and a median of -$46.8 million in 2024 frame the typical range for Amortization.
• The sharpest annual moves came in 2024 and 2025: Amortization sank 91.32% in 2024, then grew 8.39% in 2025.
• A 3-year view of Amortization shows it stood at -$25.6 million in 2023, then slumped by 91.32% to -$48.9 million in 2024, then grew by 8.39% to -$44.8 million in 2025.
• Business Quant data shows PRTC's Amortization at -$44.8 million in Q2 2025, -$48.9 million in Q4 2024, and -$48.9 million in Q2 2024.